Clinical Trials Directory

Trials / Completed

CompletedNCT01272297

The Effect of Low Intensity Shock Wave Therapy for ED in PDE5i Non Responders

The Effect of Low Intensity Shock Wave Therapy in Severe ED Patients Not Responding to Oral Medication

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
29 (actual)
Sponsor
Rambam Health Care Campus · Academic / Other
Sex
Male
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Low Intensity Shock Wave Therapy (LI-ESWT) was shown to have a beneficial effect on ED patients responding to PDE5i's. This study aimed to determine the capability of swt to convert PDE5 inhibitor non responders to sexually functioning males under PDE5i therapy.

Detailed description

We included severe ED patients (60% diabetic, 85% with cardiovascular disease) that failed to respond to PDE5i therapy, who scored 0-2 on the rigidity scale (RS) during PDE5i therapy.Treatment included 2 sessions/week for 3 weeks, repeated after a 3-week no-treatment interval. At each session LI-ESWT was applied on the penile shaft and crus for 3 minutes in 5 different penile anatomical sites (intensity of 0.09 mj/mm2, 300 shocks/site). One-month after end of treatment the same baseline assessment was repeated. An active PDE5i medication regime was then provided and final erectile function was reassessed. Main endpoints for success were changes in RS and in the International Index of Erectile Function (IIEF-ED) Domain score. We found that LI-ESWT can effectively treat severe ED patients who failed PDE5i therapy. This study further emphasises the physiological effect that LI-ESWT can have on the erectile mechanism.

Conditions

Interventions

TypeNameDescription
DEVICELI-ESWTLow intensity shock wave treatment - 12 sessions

Timeline

Start date
2010-01-01
Primary completion
2010-09-01
Completion
2010-10-01
First posted
2011-01-07
Last updated
2012-12-19

Source: ClinicalTrials.gov record NCT01272297. Inclusion in this directory is not an endorsement.